Related Experiment Video

Updated: Aug 20, 2026

Using Bioluminescent Imaging to Investigate Synergism Between Streptococcus pneumoniae and Influenza A Virus in Infant Mice
10:47

Using Bioluminescent Imaging to Investigate Synergism Between Streptococcus pneumoniae and Influenza A Virus in Infant Mice

Published on: April 14, 2011

Association between type 1 diabetes and Haemophilus influenzae type b vaccination: birth cohort study

M Karvonen1, Z Cepaitis, J Tuomilehto

  • 1Diabetes and Genetic Epidemiology Unit, National Public Health Institute, Mannerheimintie 166, FIN-00300 Helsinki, Finland. Marjatta.karvonen@ktl.fi

BMJ (Clinical Research Ed.)
|April 30, 1999
PubMed

Insights

Haemophilus influenzae type b vaccination does not appear to increase the risk of type 1 diabetes in children. Study findings indicate no significant difference in type 1 diabetes risk based on vaccination timing.

Area of Science:

  • Pediatrics
  • Immunology
  • Epidemiology

Background:

  • Type 1 diabetes is a significant childhood autoimmune disease.
  • The potential impact of routine childhood vaccinations on autoimmune disease risk is an area of ongoing research.
  • Haemophilus influenzae type b (Hib) vaccination is a widely administered childhood immunization.

Purpose of the Study:

  • To investigate the association between Haemophilus influenzae type b (Hib) vaccination and the subsequent risk of developing type 1 diabetes in a Finnish pediatric population.
  • To evaluate whether the timing of Hib vaccination influences the risk of type 1 diabetes.

Main Methods:

  • A comparative cohort study design was employed in Finland.
  • Three birth cohorts were analyzed: pre-vaccination, early vaccination (3 months), and late vaccination (24 months).
  • Cumulative incidence and relative risk of type 1 diabetes were assessed over a 10-year follow-up period using regression analysis.

Main Results:

  • No statistically significant difference in the risk of type 1 diabetes was observed between children vaccinated at 24 months and those born before the vaccination program.
  • The risk of type 1 diabetes did not significantly differ between children vaccinated early (3 months) and those vaccinated later (24 months).
  • Relative risks were consistently close to 1.0, indicating no substantial increase in type 1 diabetes risk associated with Hib vaccination.

Conclusions:

  • The findings suggest that Haemophilus influenzae type b vaccination, regardless of its timing, is unlikely to be a causal factor in the development of type 1 diabetes in children.
  • This study provides evidence against a link between Hib vaccination and type 1 diabetes, supporting its continued use in pediatric immunization schedules.
Abstract

More Related Videos

Assessing Respiratory Immune Responses to Haemophilus Influenzae06:32

Assessing Respiratory Immune Responses to Haemophilus Influenzae

Published on: June 29, 2021

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-1906:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...